DEC Business, Biosortia Pharmaceuticals will be partnering with Cincinnati Children’s Hospital Medical Center researcher.
Biosortia’s Chief Scientific Officer, Dr. Guy Carter stated: “Biosortia collaborates with the best researchers in our strategic therapy areas. We see great potential in this drug discovery project.”
